申请人:THE UNIVERSITY OF QUEENSLAND
公开号:US10947271B2
公开(公告)日:2021-03-16
The invention concerns agents with antibacterial activity, their production and use in the treatment of bacterial infections in animals, including man. The agents are derivatives of vancomycin-type antibiotics, of structure X—W-L-V, wherein X is hydrogen, acetyl or a lipophilic membrane-insertive element, W is a basic peptide or basic amino acid; L is a linking group and V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria.
本发明涉及具有抗菌活性的制剂、其生产以及在治疗动物(包括人类)细菌感染中的应用。这些制剂是万古霉素类抗生素的衍生物,结构为 X-W-L-V,其中 X 是氢、乙酰基或亲脂性膜惰性元素,W 是碱性肽或碱性氨基酸;L 是连接基团,V 是糖肽分子,可抑制细菌的肽聚糖生物合成。